Highlights Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.327 ^USD	+1.42%		-4.68%	-18.47%

Apr. 26	Aspira Women's Health Inc. Announces Minh Merchant Resigns as General Counsel, Chief Compliance Officer, and Corporate Secretary, Effective May 6, 2024	CI
Apr. 01	Cantor Fitzgerald Trims Price Target on Aspira Women's Health to $3.30 From $4, Maintains Neutral Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M	Mar. 28	MT
Aspira Women's Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Aspira Women's Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Aspira Women's Health Inc. Announces OvaSuite(SM) Distribution Agreement in the Philippines	Feb. 06	CI
Aspira Women's Health Provides Development Update on its Portfolio of Noninvasive Tests for Endometriosis	Dec. 06	CI
Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services	Nov. 27	CI
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q3 Revenue $2.2M, vs. Street Est of $2.9M	Nov. 13	MT
Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Aspira Women's Health Sees Poster on its MiRNA-Based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research	23-10-25	CI
Aspira Women's Health Signs Serum Sample Procurement Agreement With University of Oxford	23-08-31	MT
Aspira Women's Health Inc. Signs Exclusive Sample Procurement Agreement with the University of Oxford	23-08-31	CI
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Reports Q2 Revenue $2.5M, vs. Street Est of $2.8M	23-08-14	MT
Aspira Women's Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Reverse Split: 1 of 15	23-05-11	FA
Aspira Women's Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Reports Q1 Revenue $2.3M	23-05-11	MT
Aspira Women's Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of MicroRNA-Based Ovarian Cancer Test	23-05-11	CI
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.2M, vs. Street Est of $2.25M	23-03-22	MT
Aspira Women's Health Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-22	CI
Aspira Women’s Health Inc. Announces Publication of Real-World Data Validating Use of OvaWatch for Management of Adnexal Masses	23-01-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Highlights

Filters